Keeping the Record Straight

Setting the RECORD Straight.

THE FOOD AND DRUG ADMINISTRATION (FDA) REcently announced another Advisory Panel scheduled to meet in July 2010 to consider whether or not to remove rosiglitazone from the market. Central to the discussion will be the results of a recently published cardiovascular outcomes trial that randomized patients to receive rosiglitazone or alternative diabetes therapies, the RECORD trial. On February 20...

ALLHAT: setting the record straight.

The findings of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) have generated worldwide reaction from clinicians and researchers, including a recent commentary in this journal. Such response was expected for a trial of ALLHAT's size and scope, especially since its results challenged some widely held beliefs. This paper reviews key aspects of the ALLHAT ...

NAFTA: Setting the Record Straight

T HE North American Free Trade Agreement (NAFTA) was sold on the basis that it would bring a substantial expansion of US exports to Mexico and boost Mexico’s economic growth. Since its passage, however, not everything has gone as planned. In 1995 — scarcely a year after NAFTA came into effect — Mexico was in the midst of its worst economic crisis in decades. Meanwhile, rather than the anticipat...

Setting the record straight on setting the record straight: Response to the Light and Warburton rejoinder

In Light and Warburton’s (2005b) rejoinder (hereafter, Rejoinder) to our reply (DiMasi et al., 2005; hereafter, Reply), the authors reiterate some erroneous assertions made in their original comment (Light and Warburton, 2005a; hereafter, Comment) and add unsubstantiated insinuations of bias on the part of the now defunct US Congressional Office of Technology Assessment (OTA) and of academics a...

Record keeping chart…